MediWound Announces Positive Initial DataMDWD: MediWound Ltd.
2022-07-11 07:00:00
MediWound Announces Positive Initial Data from its U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
−0.77USD
−6.72 MUSD
18.69 MUSD
6.81 M
About MediWound Ltd.
Sector
CEO
Ofer Gonen
Headquarters
Yavne
Website
Employees (FY)
100
Founded
2000
ISIN
IL0011316309
FIGI
BBG005ZPKRQ4
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.
MediWound Announces Positive ResultsMDWD: MediWound Ltd.
2022-07-07 07:00:00
MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of EscharEx for Debridement of Lower Leg Ulcers
MediWound Announces Positive Results from Its U.S. Phase 2 TrialMDWD: MediWound Ltd.
2022-05-12 07:00:00
MediWound Announces Positive Results from Its U.S. Phase 2 Trial of EscharEx for Debridement of Chronic Wounds
$MDWD is gonna fall todayPupm&Dump trading strategy idea.
$MDWD is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $5,52;
stop-loss — $5,97;
take-profit — $4,62.
Do not view th
$MDWDEntry price : 5.91
Fundamentals :
- Sector: Medical Biotech
- EPS % Chg (Last Qtr): 33%
- EPS % Chg (Previous Qtr): -123%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 29%
- Sales % Chg (Previous Qtr): -81%
- 3-Year Sales Growth Rate: 183%
- Annua
MDWD LONG - TRADING IDEAMDWD micro cap coming out of a nice base - phase 3 trial results and earnings on the horizon as potential catalysts here
No Wound, Please!What I see...
+ Inside Hammer, NR7, and NR3 combo!!
+ ... with 10ma support
+ High vol.
+ MACD is flat but bullish
+ RSI at 56
+ Bollinger is narrow
+ Low price stock
- 1st Resistance at 2.18; 2nd at 2.40
- 10ma is not piercing through the body
- Very low vol. stock
What I setup...
+ Long entry ab
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MDWD is 17.19 USD — it has increased by 7.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MediWound Ltd. stocks are traded under the ticker MDWD.
MediWound Ltd. is going to release the next earnings report on May 22, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for MediWound Ltd. has a max estimate of 36.00 USD and a min estimate of 25.00 USD.
MDWD earnings for the last quarter are −0.24 USD whereas the estimation was −0.44 USD which accounts for 45.76% surprise. Estimated earnings for the next quarter are −0.26 USD. See more details about MediWound Ltd. earnings.
MediWound Ltd. revenue for the last quarter amounts to 4.78 M USD despite the estimated figure of 4.75 M USD. In the next quarter revenue is expected to reach 5.33 M USD.
Yes, you can track MediWound Ltd. financials in yearly and quarterly reports right on TradingView.
Like other stocks, MDWD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MediWound Ltd. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 100.00 employees. See our rating of the largest employees — is MediWound Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MediWound Ltd. EBITDA is −14.20 M USD, and current EBITDA margin is −75.98%. See more stats in MediWound Ltd. financial statements.